Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial — Stella

Home/Autism Spectrum Disorder/Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial

View on ClinicalTrials.gov

Recruiting

Back to Autism Spectrum Disorder trials

Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Department of Psychiatry and Behavioral Sciences, Palo Alto, California

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Stanford University

Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Enrollment target

~144 participants

Started

April 2023

Primary completion

January 2028

Age range

3 Years – 12 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.